Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12247066 | Monoclonal antibody 14F5F6 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2 | Alexis Mikes Kalergis Parra, Pablo A. Gonzalez Munoz | 2025-03-11 |
| 12195523 | Monoclonal antibody or antigen binding fragment thereof that binds to the L protein of the human parainfluenza virus (PIV); method and kit for detecting PIV | Alexis Mikes Kalergis Parra | 2025-01-14 |
| 12145980 | Monoclonal antibodies specific for the PB2 antigen of the human influenza A virus (flu), nucleotide sequences, method and diagnostic kit for flu infection | Alexis Mikes Kalergis Parra | 2024-11-19 |
| 12098185 | Monoclonal antibody 11B2C7 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2 | Alexis Mikes Kalergis Parra, Pablo A. Gonzalez Munoz | 2024-09-24 |
| 12065484 | Specific monoclonal antibody against the N antigen of human respiratory syncytial virus (hRSV) useful for treating infection, detection thereof and diagnosis | Alexis Mikes Kalergis Parra | 2024-08-20 |
| 11873331 | Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV | Alexis Mikes Kalergis Parra, Jorge Eugenio Mora Alarcon | 2024-01-16 |
| 11085080 | Use of IL-3, IL-33 and IL-12p40 as markers for characterization of respiratory infections by respiratory syncytial virus | Alexis Mikes Kalergis Parra, Jose Pablo Bertrand Navarrete, Margarita Kam-Lem Lay Remolcoi | 2021-08-10 |
| 11065301 | Pharmaceutical composition for ameliorating the symptoms and disease of the respiratory infection caused by human metapneumovirus (HMPV), which comprises at least one agent that neutralizes the function of TSLP and/or TSLPR and/or OX40L and/or CD177 molecules, and a pharmaceutically acceptable excipient, and use thereof | Alexis Mikes Kalergis Parra, Margarita Kam-Lem Lay Remolcoi | 2021-07-20 |
| 10858419 | Monoclonal antibodies specifically for the antigen P of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by RSV | Alexis Mikes Kalergis Parra, Jorge Eugenio Mora Alarcon | 2020-12-08 |
| 10766948 | Monoclonal antibodies specific for the pIII antigen of human Adenovirus (ADV), produced and secreted by cell hybridomas, useful for detection and diagnosis of ADV infection | Alexis Mikes Kalergis Parra, Jorge Eugenio Mora Alarcon | 2020-09-08 |
| 9999663 | Immunogenic formulation containing recombinant live BCG that express antigens of metapneumovirus (hMPV), in a suspension prepared from a lyophilisate, without requiring an adjuvant, suitable for pharmaceutical use | Alexis Mikes Kalergis Parra, Christian Palavecino Beaumont | 2018-06-19 |
| 9995747 | Specific monoclonal antibodies of the antigen M of the human metapneumovirus (HMPV) and use thereof in a diagnostic method | Alexis Mikes Kalergis Parra, Jorge Eugenio Mora Alarcon | 2018-06-12 |
| 9273122 | Monoclonal antibodies specific for the M2-1 antigen of respiratory syncytial virus (RSV) | Alexis Mikes Kalergis Parra, Jorge Eugenio Mora Alarcon, Roberto Sebastian Gomez Johnson | 2016-03-01 |
| 8398993 | Immunogenic formulation | Alexis Mikes Kalergis Parra, Pablo A. Gonzalez Munoz | 2013-03-19 |